Coagulation factor VIII partners in the intrinsic tenase complex (FVIII-FIXa-FX)

The intrinsic tenase complex is a multi-component enzyme assembly essential for the amplification phase of the blood coagulation cascade. It is composed of the serine protease activated Factor IX (FIXa), the non-enzymatic cofactor activated Factor VIII (FVIIIa), calcium ions, and a procoagulant phospholipid surface typically provided by activated platelets (UniProt P00451). The primary biological role of this complex is the proteolytic activation of Factor X to Factor Xa, a step that is critical for the subsequent generation of a large burst of thrombin required for stable clot formation (StatPearls NBK507795). Factor VIIIa acts as a scaffold, precisely orienting FIXa and Factor X to increase the catalytic efficiency of the reaction by several orders of magnitude. Deficiencies or functional defects in the partners of this complex, particularly Factor VIII or Factor IX, result in the bleeding disorders Hemophilia A and Hemophilia B, respectively. Therapeutic interventions include replacement of the missing factors or the use of bispecific antibodies like emicizumab, which mimics the cofactor function of FVIIIa by simultaneously binding FIXa and Factor X to restore tenase activity (PubMed 30117045). Monitoring of this target is typically performed via coagulation assays such as aPTT or specific factor activity tests, while safety concerns focus on the risk of over-activation leading to thrombosis or the development of neutralizing antibodies.

Other names

Intrinsic tenase complexFactor VIIIa-Factor IXa complexFIXa-FVIIIa-FX complexTenase complex

Factor VIIIa acts as a non-enzymatic cofactor that binds to both the enzyme (Factor IXa) and the substrate (Factor X) on a phospholipid membrane, facilitating their optimal orientation and increasing the rate of Factor X activation by approximately 200,000-fold (StatPearls NBK507795).